Asthma: all 4,012 studies
Page 35 of 41. Open to participants first (515), then studies with results posted, then the rest; newest registration first within each.
- Cohort Study of the Patterns of Microvesicles in the Serum of Participants With Atopic and Non-atopic AsthmaCompletedNCT00700726
- A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)CompletedNCT00700661Phase 3
- A Reminder System for Paper-Based Asthma Guidelines in the Pediatric Emergency DepartmentCompletedNCT00699439Not applicable
- Effect of Montelukast on the Airway RemodelingCompletedNCT00699062Phase 4
- Repeated High-dose Inhaled Corticosteroids for AsthmaWithdrawnNCT00695604Phase 2
- Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic SubjectsCompletedNCT00691951Phase 3
- Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled CorticosteroidsCompletedNCT00691873Phase 4
- Evaluation of Lovastatin in Severe Persistent AsthmaWithdrawnNCT00689806Phase 1/2
- Maternal Variables Associated With Adherence in Children With AsthmaStatus unknownNCT00688792
- Does Tailored Education in Asthma Care Help Improve Patient Satisfaction, Adherence, and Quality of Life (TEACH) TrialCompletedNCT00687310Phase 4
- Comparison of On-line and Off-line Measurements of Exhaled Nitric Oxide (NO)Status unknownNCT00686309
- Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic AlbuterolCompletedNCT00685425Phase 3
- Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric SubjectsCompletedNCT00685347Phase 2
- Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With AsthmaCompletedNCT00685022Phase 2
- Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With AsthmaCompletedNCT00684866Phase 2
- A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With AsthmaCompletedNCT00684827Phase 2
- Asthma and Mindfulness-Based Stress Reduction (MBSR)CompletedNCT00682669Phase 1/2
- Asthma Patient Survey Study to Assess Asthma Effect and Medication in FinlandCompletedNCT00681382
- Comparative Effects of Fish Oil Supplementation and a Montelukast on EIB and Airway Inflammation in AsthmaCompletedNCT00676468Phase 1
- Influence of Propofol on Alveolar Macrophage in Asthmatic PatientsCompletedNCT00676416
- A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent AsthmaWithdrawnNCT00675649Phase 2
- Effects of Montelukast in Children With AsthmaCompletedNCT00675285Phase 3
- A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmaticsCompletedNCT00673621Phase 1
- Orthomolecular Therapy and Asthma in ChildrenStatus unknownNCT00672529Phase 2
- Role of TLR4 in Environmental AsthmaCompletedNCT00671892Phase 1
- Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen ChallengeTerminatedNCT00671593Phase 1
- Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1CompletedNCT00671229
- Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT00667797Phase 4
- Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in AsthmaCompletedNCT00667407Phase 3
- Oral Contraceptives and Asthma ControlWithdrawnNCT00662051
- Inhaled Corticosteroids on Airway Smooth Muscle in AsthmaWithdrawnNCT00661973Phase 4
- Utilization Patterns of Pulmicort in Real Life PracticeCompletedNCT00660569
- Using the Telephone to Improve Care in Childhood AsthmaCompletedNCT00660322Not applicable
- Non-Interventional Study of Cough Variant Asthma Treatment With Pulmicort®Respules® in Children OutpatientsCompletedNCT00660114
- A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With AsthmaCompletedNCT00659659Phase 1
- A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled AsthmaCompletedNCT00658749Phase 1
- Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis TurbuhalerCompletedNCT00658255Phase 2
- The Effect of Xolair (Omalizumab) on Allergy Blood CellsCompletedNCT00657891Phase 4
- A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal GlandsCompletedNCT00657774Phase 1
- Add-on Salmeterol Versus Montelukast in Arg/Arg-16 AsthmaticsCompletedNCT00655616Not applicable
- Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEMCompletedNCT00652392Phase 3
- Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite AllergyCompletedNCT00652223Phase 1/2
- Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5CompletedNCT00652002Phase 3
- Titratable Dosing in Moderate to Severe AsthmaticsCompletedNCT00651768Phase 3
- Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5CompletedNCT00651651Phase 3
- Symbicort in Asthmatic Children - SEEDLINGCompletedNCT00651547Phase 3
- A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and AdultsCompletedNCT00649025Phase 3
- A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019)CompletedNCT00646789Phase 1
- Symbicort Onset of Action 1CompletedNCT00646620Phase 3
- Atlantis SymbicortCompletedNCT00646594Phase 3
- Long-Term Safety of Symbicort in Asthmatic Children - SAPLINGCompletedNCT00646529Phase 3
- Gemini Symbicort pMDICompletedNCT00646516Phase 3
- Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUTCompletedNCT00646321Phase 3
- Symbicort Onset of Action 2CompletedNCT00646009Phase 3
- Genetics of Asthma - Bronchoscopy StudiesTerminatedNCT00644514Phase 1
- Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies RecordingStatus unknownNCT00644462
- New Version Pulmicort Turbuhaler USA AdultsCompletedNCT00642187Phase 3
- New Version Pulmicort Turbuhaler USA ChildrenCompletedNCT00642161Phase 3
- Adults With Moderate to Severe AsthmaCompletedNCT00642122Phase 3
- Inhaled Steroid Treatment as Regular Therapy in Early AsthmaCompletedNCT00641914Phase 4
- Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, ChildrenCompletedNCT00641472Phase 4
- Varicella Vaccination With PulmicortCompletedNCT00641446Phase 4
- Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ RecordingCompletedNCT00640120
- This Study Compared an in Home Asthma Management Program Provided by Nurses or Respiratory TherapistCompletedNCT00639847Not applicable
- A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal TherapyCompletedNCT00639691Phase 4
- Efficacy Study of Herbal Formula CUF2 to Treat Childhood AsthmaCompletedNCT00636103Phase 1/2
- Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic PatientsTerminatedNCT00635505Phase 3
- Biomarkers in Exhaled Breath From Asthmatic PatientsTerminatedNCT00635271
- 4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric AsthmaTerminatedNCT00634517Phase 3
- CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic RhinitisStatus unknownNCT00631254Not applicable
- Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild AsthmaTerminatedNCT00630461Phase 1
- The Analysis of BMI, Asthma Prevalence, and Lung Functions of Schoolchildren in Southern TaiwanCompletedNCT00629785
- Adult Asthmatics and Acid RefluxCompletedNCT00628953Phase 2
- REALL: A Retrospective Observational Study to Compare the Effectiveness and Cost-Effectiveness Between Different Step-3 Asthma Treatment StrategiesCompletedNCT00628563
- Vitamin A, Its Receptors and AsthmaWithdrawnNCT00628329
- Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized PatientsCompletedNCT00627731Phase 4
- Role of Cigarette Smoking in Regulating Allergen-induced Early and Late Responses in Mild AsthmaticsCompletedNCT00626171Early Phase 1
- Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent AsthmaCompletedNCT00624702Phase 1
- A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start ChildrenStatus unknownNCT00624429Phase 4
- Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen ExtractTerminatedNCT00622362Phase 2
- Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 PolymorphismsCompletedNCT00621829Not applicable
- Predicting the Diagnosis of AsthmaCompletedNCT00620334
- Study to Evaluate the Impact of Obesity on Airway Inflammation and Mechanics in AsthmaticsCompletedNCT00615706
- Study to Evaluate the Effects of Weight Loss on Airway Inflammation and Mechanics in Subjects With Asthma (Asthma-Bariatric Surgery Study)CompletedNCT00615498
- A Pilot Evaluation of the Impact of Alcohol Use on Airway Inflammation and Mechanics in AsthmaticsWithdrawnNCT00615407
- Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent AsthmaCompletedNCT00608218
- Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in AsthmaCompletedNCT00606242Phase 4
- Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat AsthmaWithdrawnNCT00604578Phase 2
- Mechanisms of Acute Asthma Exacerbations Through Molecular Analysis of Airway Secretions and TissuesCompletedNCT00603629
- Safety Study of Chinese Herbal Therapy to Treat AsthmaCompletedNCT00601263Phase 1
- Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic AsthmaWithdrawnNCT00598104Phase 1/2
- Inflammatory, Functional and Image Composite Measure to Define Asthma ControlStatus unknownNCT00597064Phase 4
- Mechanisms of Exacerbation of AsthmaTerminatedNCT00594750
- Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental FactorsCompletedNCT00590304
- Asthma in the Delta Region of Arkansas (ADRA): Prevalence and MorbidityCompletedNCT00589719
- Mannitol Bronchoprovocation Challenge Ancillary Study/ACRNCompletedNCT00585260Early Phase 1
- Pulmicort Respules on Relapse Rates After Treatment in the EDWithdrawnNCT00584636Phase 4
- Menstrual Differences in Airway Inflammation in AsthmaCompletedNCT00584441
- Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma SeverityTerminatedNCT00584051
- Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPDCompletedNCT00583986Phase 3